SAM
CLVS

Sectoral Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Sectoral Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-443,397
Closed -$13M – 148
2018
Q3 		$13M Buy
443,397
+74,698
+20% +$2.89M 1.38% 26
2018
Q2 		$16.8M Buy
368,699
+47,900
+15% +$2.33M 1.87% 21
2018
Q1 		$16.9M Buy
320,799
+138,199
+76% +$8.06M 1.86% 21
2017
Q4 		$12.4M Sell
182,600
-69,099
-27% -$4.83M 1.55% 27
2017
Q3 		$20.7M Buy
251,699
+219,799
+689% +$17.4M 2.67% 15
2017
Q2 		$2.99M Buy
+31,900
New +$1.95M 0.33% 45
2015
Q3 		– Sell
-246,952
Closed -$21.7M – 93
2015
Q2 		$21.7M Sell
246,952
-2,200
-0.9% -$188K 0.91% 34
2015
Q1 		$18.5M Sell
249,152
-174,300
-41% -$12.3M 0.7% 42
2014
Q4 		$23.7M Buy
+423,452
New +$22.3M 1.06% 34
2014
Q3 		– Sell
-314,952
Closed -$13M – 72
2014
Q2 		$13M Sell
314,952
-178,448
-36% -$9.19M 0.55% 46
2014
Q1 		$34.2M Buy
493,400
+21,000
+4% +$1.54M 1.41% 28
2013
Q4 		$28.5M Buy
472,400
+46,200
+11% +$2.51M 1.23% 27
2013
Q3 		$25.9M Buy
426,200
+213,500
+100% +$15.1M 1.25% 27
2013
Q2 		$14.2M Buy
+212,700
New +$9.56M 0.42% 44

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Sectoral Asset Management's CLVS Position: Q4 2018 in Review

Sectoral Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 443,397 shares — an estimated $13M sold.

Sectoral Asset Management first reported a position in CLVS in Q2 2013 and held it in 14 quarters. The position peaked at $34.2M in Q1 2014. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

  • Sectoral Asset Management reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
  • Sectoral Asset Management sold 443,397 Clovis Oncology, Inc. shares in Q4 2018, an estimated $13M.
  • Sectoral Asset Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 14 quarters.
  • Sectoral Asset Management's Clovis Oncology, Inc. position peaked at $34.2M in Q1 2014.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on Sectoral Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.